Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
KIRKWOOD, JOHN
One or more keywords matched the following items that are connected to KIRKWOOD, JOHN
Item TypeName
Concept Imidazoles
Academic Article Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Academic Article Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect.
Academic Article A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.
Academic Article The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.
Academic Article Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Academic Article Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial.
Academic Article Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma.
Academic Article Reply to E. Hindi? and K.R. Hess.
Academic Article Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial.
Academic Article Systemic Therapy for Melanoma: ASCO Guideline.
Academic Article Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Search Criteria
  • Imidazoles